Should the FDA mandate that autologous units drawn and transfused within a single institution be tested for markers of infectious disease?
Perkins
J
J
Kaminer
L
L
Kruskall
M
M
Cannon
M
M
Uhl
L
L
Dzik
W
W
Silver
H
H
O'Neill
M
M
Popovsky
M
M
King
K
K
Ness
P
P
AuBuchon
J
J
Shapiro
A
A
Yomtovian
R
R
Petz
L D
LD
D001804:Blood Transfusion, Autologous / Q000191:economics / Q000331:legislation & jurisprudence*; D003140:Communicable Disease Control / Q000331:legislation & jurisprudence*; D003141:Communicable Diseases / Q000097:blood* / Q000175:diagnosis / Q000635:transmission; D004469:Economics, Hospital; D006801:Humans; D019300:Medical Errors; D012449:Safety; D014481:United States; D014486:United States Food and Drug Administration